Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage(R) XR

TORONTO, Feb. 24, 2017 -- (Healthcare Sales & Marketing Network) -- Intellipharmaceutics International Inc. (IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development an... Biopharmaceuticals, Generics, FDA Intellipharmaceutics, metformin, Glucophage, diabetes
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news